Inactive Instrument

Press Releases PERE PHARP Nasdaq

Equities

US7136614036

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

Avid Bioservices to Report Financial Results for Quarter and Fiscal Year Ended April 30, 2018 After Market Close on July 16, 2018	18-07-09	GL
Avid Bioservices Added to Russell 3000® Index and Russell 2000® Index	18-06-25	GL
Avid Bioservices to Participate at BIO International Convention 2018	18-05-29	GL
Avid Bioservices Announces Appointment of Magnus Schroeder, Ph.D., as Vice President of Process Sciences	18-05-08	GL
Avid Bioservices Provides Update on Ongoing Expansion of Process Development Capabilities and Laboratory Infrastructure	18-04-24	GL
Avid Bioservices to Participate at INTERPHEX 2018	18-04-09	GL
Avid Bioservices to Participate at Upcoming CDMO Industry Conferences	18-03-13	GL
Avid Bioservices Reports Financial Results for Third Quarter of Fiscal Year 2018 and Recent Developments	18-03-12	GL
Avid Bioservices Declares Quarterly Dividend on Its Series E Convertible Preferred Stock	18-03-07	GL
Avid Bioservices to Present at the 30th Annual ROTH Conference	18-03-06	GL
Avid Bioservices to Report Financial Results for Third Quarter of Fiscal Year 2018 After Market Close on March 12, 2018	18-03-05	GL
Avid Bioservices Selected by Acumen Pharmaceuticals to Lead Process Development and Clinical Manufacture of Novel Alzheimer’s Disease Candidate	18-03-01	GL
Avid Bioservices Announces Resignation of Chief Financial Officer	18-02-26	GL
Avid Bioservices Selected as Commercial Manufacturer for Critical Enzyme Replacement Therapy by Enzyvant, a Subsidiary of Roivant Sciences	18-02-21	GL
Avid Bioservices Announces Closing of Public Offering of Common Stock	18-02-20	GL
Avid Bioservices Announces Pricing of Public Offering of Common Stock	18-02-15	GL
Avid Bioservices Announces Proposed Offering of Common Stock	18-02-14	GL
Avid Bioservices and Oncologie Enter Into Asset Assignment and Purchase Agreement for Avid’s PS-Targeting Program Including Bavituximab	18-02-12	GL
Avid Bioservices to Present at NobleCon14	18-01-23	GL
Peregrine Pharmaceuticals Announces Name Change to Avid Bioservices as Part of Transition to Dedicated Contract Development and Manufacturing Organization (CDMO)	18-01-05	GL

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases PERE PHARP Nasdaq

Equities

US7136614036

Press Releases

Filters